• Asia

    Quintiles operates facilities in about 20 Asian cities, from Singapore to Seoul, Beijing to Bangalore, Tokyo to Taipei. These locations are part of our infrastructure that enables the transfer of best practices around the globe.
  • Asia Perspectives

  • Quintiles

    Middle East Oncology Capabilities

    Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates. Read fact sheet

  • Quintiles

    EIU Emerging China

    This Economist Intelligence Unit study, sponsored by Quintiles, looks at China’s growing pharmaceutical market and its implications for the global life sciences sector.   Read white paper